Vanguard Group Inc Seres Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $4.96 Trillion
  • Q1 2024

A detailed history of Vanguard Group Inc transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 6,734,821 shares of MCRB stock, worth $5.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,734,821
Previous 6,005,307 12.15%
Holding current value
$5.05 Million
Previous $8.41 Million 38.33%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$0.75 - $1.56 $547,135 - $1.14 Million
729,514 Added 12.15%
6,734,821 $5.19 Million
Q4 2023

Feb 14, 2024
BUY
$0.93 - $2.15 $491,563 - $1.14 Million
528,563 Added 9.65%
6,005,307 $8.41 Million
Q3 2023

Nov 14, 2023
BUY
$2.33 - $5.07 $278,577 - $606,174
119,561 Added 2.23%
5,476,744 $13 Million
Q2 2023

Aug 14, 2023
SELL
$4.67 - $6.55 $2.32 Million - $3.25 Million
-495,953 Reduced 8.47%
5,357,183 $25.7 Million
Q1 2023

May 15, 2023
SELL
$4.95 - $6.09 $1.19 Million - $1.46 Million
-239,801 Reduced 3.94%
5,853,136 $33.2 Million
Q4 2022

Feb 10, 2023
SELL
$5.09 - $9.05 $2.64 Million - $4.69 Million
-517,919 Reduced 7.83%
6,092,937 $34.1 Million
Q3 2022

Nov 14, 2022
BUY
$3.5 - $7.2 $4.48 Million - $9.22 Million
1,280,039 Added 24.01%
6,610,856 $42.4 Million
Q2 2022

Aug 12, 2022
BUY
$2.7 - $7.62 $712,494 - $2.01 Million
263,887 Added 5.21%
5,330,817 $18.3 Million
Q1 2022

May 13, 2022
BUY
$6.3 - $8.84 $2.46 Million - $3.45 Million
390,665 Added 8.35%
5,066,930 $36.1 Million
Q4 2021

Feb 14, 2022
BUY
$6.02 - $11.43 $4.33 Million - $8.23 Million
719,993 Added 18.2%
4,676,265 $39 Million
Q3 2021

Nov 12, 2021
BUY
$5.46 - $22.6 $3.01 Million - $12.4 Million
550,702 Added 16.17%
3,956,272 $27.5 Million
Q2 2021

Aug 13, 2021
BUY
$18.46 - $24.36 $62.9 Million - $83 Million
3,405,570 New
3,405,570 $81.2 Million

Others Institutions Holding MCRB

# of Institutions
100
Shares Held
62.7M
Call Options Held
36.9K
Put Options Held
476K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $93.1M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email